Science
Scientific understanding of the gut microbiome has grown exponentially in recent years and the research world is booming with studies showing that modifications in the intestinal bacteria and inflammation may play a role in the development of many common chronic diseases.
The Akkermansia Company™ is dedicated to sharing useful articles based on the latest scientific research covering areas relating to the Akkermansia muciniphila strain, gut health and the microbiome.
About Akkermansia muciniphila
The Gut Microbiome
Safeguarding Gut Barrier Health
The Prevalence of Obesity & Diabetes
Understanding Irritable Bowel Syndrome
Irritable bowel syndrome, known as IBS for short, is a chronic gastrointestinal disorder affecting the large intestine. It is believed around 1 in 10 people worldwide live with the condition. 5
REFERENCES
1 Derrien M, Belzer C, de Vos WM (2017) Akkermansia muciniphila and its role in regulating host functions. Microb Pathog 106:171-181. doi:10.1016/j.micpath.2016.02.005.
2 Tierney, B. T., et al. (2019). “The Landscape of Genetic Content in the Gut and Oral Human Microbiome.” Cell Host & Microbe 26(2): 283-295.e288
3 Martel, J., et al. (2022). “Gut barrier disruption and chronic disease.” Trends in Endocrinology & Metabolism 33(4): 247-265
4 de Vos, W. M., et al. (2022). “Gut microbiome and health: mechanistic insights.” Gut 71(5): 1020-1032
5 IBS Facts and Statistics, https://aboutibs.org/what-is-ibs/facts-about-ibs/